Trexquant Investment’s Oric Pharmaceuticals ORIC Stock Holding History

Trexquant Investment’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$304K	Buy	+23,972	New	+$272K	﹤0.01%	1593
2025 Q2	–	Sell	-76,093	Closed	-$425K	–	1782
2025 Q1	$425K	Buy	+76,093	New	+$665K	﹤0.01%	1323
2024 Q4	–	Sell	-25,220	Closed	-$259K	–	1779
2024 Q3	$259K	Buy	+25,220	New	+$249K	﹤0.01%	1387
2023 Q3	–	Sell	-19,981	Closed	-$155K	–	1721
2023 Q2	$155K	Buy	+19,981	New	+$113K	﹤0.01%	1345
2022 Q2	–	Sell	-53,760	Closed	-$287K	–	1763
2022 Q1	$287K	Buy	+53,760	New	+$484K	0.01%	1029

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Trexquant Investment's ORIC Position: Q1 2026 in Review

Trexquant Investment opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2026: 23,972 shares worth $304K. The stake represents ﹤0.01% of the portfolio and ranks #1593 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in ORIC as recently as Q1 2025.

Trexquant Investment first reported a position in ORIC in Q1 2022 and has held it in 5 quarters since. The position peaked at $425K in Q1 2025. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

Trexquant Investment held 23,972 shares of Oric Pharmaceuticals worth $304K as of Q1 2026.
Oric Pharmaceuticals was a new Trexquant Investment position in Q1 2026.
Oric Pharmaceuticals made up ﹤0.01% of Trexquant Investment's portfolio in Q1 2026, its #1593 holding.
Trexquant Investment first reported a position in Oric Pharmaceuticals in Q1 2022 and has held it in 5 quarters since.
Trexquant Investment's Oric Pharmaceuticals position peaked at $425K in Q1 2025.
182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.